4,4,4-TRIFLUORO-2-HYDROXYBUTANOIC ACID, 95.0%, 250mg

2-(2-Chloropyrimidin-4-yl)propan-2-ol, 1g

6-methoxy-1H,4H-pyrido[3,4-d]pyrimidin-4-one, 98%, 1g

L(+)-tartaric acid, min. 99.5%, pa, ACS, ISO, 250 g, plastic packaging.

N-(2,6-Dichloro-4-methoxyphenyl)acetamide, 95.0%, 250mg

5-methyl-1H-pyrazole-4-carbaldehyde, 95.0%, 10g

6-Methylquinoxaline, 99.0%, 25g

3-ETHYNYLOXETANE, 95.0%, 1g

2,2-Dimethylmalonamide, 97.0%, 5g

Ethyl 2-phenyl-3-(trifluoromethyl)pyrazole-4-carboxylate, 95.0%, 100g

1-Cyclohexenyl trifluoromethanesulfonate, 95.0%, 5g

(METHYLSULFONIMIDOYL)BENZENE, 95%, 5g

2-Aminobenzenesulfonamide, 95.0%, 1g